23/05/2023
23/05/2023
EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation
10/05/2023
10/05/2023
#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee
10/05/2023
10/05/2023
Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski
25/04/2022
25/04/2022

Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

Do you like it?
Read more
08/09/2021
08/09/2021

Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies

Do you like it?
Read more
20/07/2021
20/07/2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

Do you like it?
Read more
16/06/2021
16/06/2021

EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines

Do you like it?
Read more
20/05/2021
20/05/2021

Advanced Therapies bring tranformational value to European patients

Do you like it?
Read more
12/02/2021
12/02/2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

EuropaBio sees the Directive on cross-border healthcare as an important instrument to ensure patient access to the best available care. The Directive is particularly relevant for advanced therapies and medicines for rare diseases.
Do you like it?
Read more
03/03/2017
03/03/2017

EuropaBio statement on European Parliament report on EU options for improving access to medicines

EuropaBio notes the adoption by the European Parliament of the report on EU options for improving patient access to medicines on 2 March 2017, in Brussels.
Do you like it?
Read more